I understand the premise of them being a developmental stage company. However, I personally wouldn't put them in that category after 5+ years under current leadership and several more years prior to that. I'd call it a turnaround situation that's taken along time to turn around. One indicator that I'm not too excited about is that, in the past anytime the company had an order or potential order - they made a point to broadcast it. Recently, the 12k order. Has there been an announcement of more orders since then or is that pretty much it for now?
Lastly, if you look at any established company, annual revenues on the average are 20% to 25% of market cap. Nanologix revenue is 0.001% of market cap. It's not a screaming buy. There's no question that is over priced drastically. I don't believe there's a business owner in the country that would currently pay more than $0.03 per share to purchase the entire business. Anything more is roulette.